نتایج جستجو برای: herpes zoster neuralgia

تعداد نتایج: 47192  

Journal: :The Journal of the American Osteopathic Association 2007
M Susan Burke

This review of the data from the Shingles Prevention Study (SPS) highlights the efficacy and safety of a high-titer live attenuated herpes zoster virus vaccine in preventing herpes zoster and postherpetic neuralgia (PHN) in adults aged 60 years or older. In the SPS, the vaccine reduced the burden of illness due to herpes zoster disease by 61.1% and the incidence of its most common and debilitat...

Journal: :The Journal of the American Osteopathic Association 2007
Katherine E Galluzzi

Evidence-based strategies for the management of herpes zoster and postherpetic neuralgia (PHN) include the use of antiviral agents in acute zoster and specific analgesics in PHN. Antiviral agents are effective in reducing the severity and duration of acute herpes zoster when given within 72 hours of rash onset, but they do not prevent PHN. Anticonvulsants, tricyclic antidepressants, opioids, an...

2011
Sanjay Kumar Kanodia K. C. Singhal

BACKGROUND Herpes zoster is an intractable painful condition. The pain during first thirty days of onset is known as acute herpetic neuralgia. Multiple treatments using NSAIDS, opioids and tricyclic antidepressants are available but the role of pregabalin in acute Herpetic Neuralgia is not assessed in any of Indian studies. PURPOSE This study was aimed to determine efficacy and safety of Preg...

Journal: :Ophthalmology 2008
Lawrence D Gelb

TOPIC The role of the zoster vaccine in the prevention of herpes zoster and its sequelae, including postherpetic neuralgia (PHN) and herpes zoster ophthalmicus. CLINICAL RELEVANCE Wide administration of the herpes zoster vaccine in accordance with the recommendations of the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) will lead to a decline in...

Journal: :Archives of family medicine 2000
S K Tyring K R Beutner B A Tucker W C Anderson R J Crooks

OBJECTIVE To compare the efficacy and safety of valacyclovir hydrochloride and famciclovir for the treatment of herpes zoster. DESIGN A double-blind, randomized, controlled, multicenter clinical trial in which patients received 7 days of treatment and were followed up for 24 weeks. SETTINGS Patients reported directly to specialist centers or were referred from primary care centers. PATIEN...

Journal: :Bulletin de la Societe belge d'ophtalmologie 2002
J E R Devulder

Postherpetic ophthalmic neuralgia is the final stage of a varicella zoster infection. Many years after chickenpox infection, patients can develop herpes zoster in one or more specific dermatomal regions. The ophthalmic branch of the trigeminal nerve and the thoracic nerves are most commonly affected. Younger patients are less prone to postherpetic neuralgia than the older. Patients with a depre...

2011
Younghoon Jeon Sung Uk Baek Jin Seok Yeo

Postherpetic neuralgia is the most frequent complication of herpes zoster. Treatment of this neuropathic pain syndrome is difficult and often disappointing. Although postherpetic neuralgia is generally a self-limited condition, it can last indefinitely. Continuous epidural blockade for patients with acute zoster can shorten the duration of treatment. However, continuous epidural block has some ...

Journal: :Archives of dermatology 1998
S E Chiarello

Twenty-six patients with herpetic neuralgia were divided into 2 groups. Group 1 consisted of 13 patients with acute herpetic neuralgia, arbitrarily defined as pain beginning from 0 days to 3 months after the onset of herpes zoster infection. Group 2 consisted of 13 patients treated during the course of the postherpetic neuralgia, arbitrarily defined as pain lasting 3 months or more from the ons...

Journal: :The New England journal of medicine 2016
Anthony L Cunningham Himal Lal Martina Kovac Roman Chlibek Shinn-Jang Hwang Javier Díez-Domingo Olivier Godeaux Myron J Levin Janet E McElhaney Joan Puig-Barberà Carline Vanden Abeele Timo Vesikari Daisuke Watanabe Toufik Zahaf Anitta Ahonen Eugene Athan Jose F Barba-Gomez Laura Campora Ferdinandus de Looze H Jackson Downey Wayne Ghesquiere Iris Gorfinkel Tiina Korhonen Edward Leung Shelly A McNeil Lidia Oostvogels Lars Rombo Jan Smetana Lily Weckx Wilfred Yeo Thomas C Heineman

BACKGROUND A trial involving adults 50 years of age or older (ZOE-50) showed that the herpes zoster subunit vaccine (HZ/su) containing recombinant varicella-zoster virus glycoprotein E and the AS01B adjuvant system was associated with a risk of herpes zoster that was 97.2% lower than that associated with placebo. A second trial was performed concurrently at the same sites and examined the safet...

2005
M. N. Oxman M. J. Levin G. R. Johnson K. E. Schmader S. E. Straus R. D. Arbeit M. S. Simberkoff A. A. Gershon L. E. Davis A. Weinberg K. D. Boardman H. M. Williams J. Hongyuan Zhang P. N. Peduzzi C. E. Beisel V. A. Morrison J. C. Guatelli P. A. Brooks C. A. Kauffman R. N. Greenberg R. Harbecke T. C. Kyriakides C. Y. Chan I. S. F. Chan W. W. B. Wang P. W. Annunziato J. L. Silber

The authors’ affiliations are listed in the Appendix. Address reprint requests to Dr. Oxman at the Shingles Prevention Study (Mail code 111F-1), VA San Diego Healthcare System, 3350 La Jolla Village Dr., San Diego, CA 92161, or at mnoxman@ucsd. edu. *Other members of the Shingles Prevention Study Group are listed in the Appendix. N Engl J Med 2005;352:2271-84. Copyright © 2005 Massachusetts Med...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید